Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Ovarian Neoplasms |
Free Subscription
1 BMC Cancer |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by
promoting pyroptosis.
BMC Cancer. 2024;24:551.
PubMed
Abstract available
A cellular model provides insights into the pathogenicity of the oncogenic FOXL2
somatic variant p.Cys134Trp.
Br J Cancer. 2024;130:1453-1462.
PubMed
Abstract available
Walking the tightrope: Fertility preservation among hereditary breast and ovarian
Cancer syndrome Previvors.
Gynecol Oncol. 2024;186:176-181.
PubMed
Abstract available
"Having cancer is very expensive": A qualitative study of patients with ovarian
cancer and PARP inhibitor treatment.
Gynecol Oncol. 2024;186:170-175.
PubMed
Abstract available
Extended-duration antibiotics are not associated with a reduction in surgical
site infection in patients with ovarian cancer undergoing cytoreductive surgery
with large bowel resection.
Gynecol Oncol. 2024;186:161-169.
PubMed
Abstract available
Effect of surgical volume on short-term outcomes of cytoreductive surgery for
advanced-stage ovarian cancer: A population-based study from the Dutch
Gynecological Oncology Audit.
Gynecol Oncol. 2024;186:144-153.
PubMed
Abstract available
Gene expression markers in peripheral blood and outcome in patients with
platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Int J Cancer. 2024 Apr 27. doi: 10.1002/ijc.34978.
PubMed
Abstract available
Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals
association of TP53 mutations with platinum resistance when combined with gene
expression.
Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34908.
PubMed
Abstract available
Prognostic impact of erythropoietin-stimulating agent use during front-line
chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study.
Int J Gynaecol Obstet. 2024 Apr 29. doi: 10.1002/ijgo.15533.
PubMed
Abstract available
OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming
and can be synthetically targeted by CA9 inhibition.
Proc Natl Acad Sci U S A. 2024;121:e2315348121.
PubMed
Abstract available
Thank you for your interest in scientific medicine.